Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. This action involves an approved product …
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Inflammation and Insulin Resistance in Rheumatoid Arthritis [NA]
This update reports the completion of a clinical trial evaluating inflammation and insulin resistance in rheumatoid arthritis, with results …
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs. [Phase 4]
Phase 4 study assessing the effect of tocilizumab on neutrophil counts in patients with active rheumatoid arthritis who had an inadequate re…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 trial evaluating tocilizumab (RoActemra/Actemra) in combination with DMARDs versus current best-practice DMARD therapy in rheumatoid…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies [Phase 3]
A Phase 3 study evaluating rituximab retreatment in rheumatoid arthritis patients with inadequate response to anti-TNF therapies has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy [Phase 3]
Phase 3 clinical trial update of Rituximab in combination with methotrexate in rheumatoid arthritis patients with inadequate response to DMA…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating infliximab in combination with methotrexate for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies. [Phase 4]
Phase 4 trial evaluating rituximab in combination with methotrexate for rheumatoid arthritis patients with inadequate response to anti-TNF t…
-
FDA approval · 2014-11-02FDA Approved: NAPROXEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Naproxen by Amneal Pharmaceuticals of New York LLC (generic Naproxen).
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab [Phase 2]
Phase 2 clinical trial update reporting results for rheumatoid arthritis patients who completed the preceding M13-390 study and were treated…
-
FDA approval · 2014-10-29FDA Approved: CELECOXIB — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic version of celecoxib (Celecoxib) under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Observational Study of Meloxicam in Any Labeled Indication
Boehringer Ingelheim reports the completion of an observational study evaluating meloxicam across any labeled indication, including rheumato…
-
CLINICAL_TRIALS research · 2014-10-27Clinical Trial Update: Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis [Phase 4]
This is a Phase 4 clinical trial comparing iguratimod plus methotrexate to leflunomide plus methotrexate in rheumatoid arthritis, sponsored …
-
FDA approval · 2014-10-25FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. to market a generic cyclophosphamide product.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI [Phase 4]
Phase 4 trial evaluating the effectiveness of Iguratimod versus placebo for early rheumatoid arthritis using MRI outcomes.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]
This clinical trial update reports results from a Phase 2 study comparing infusion rates of tocilizumab in adults with moderate to severe rh…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER) [Phase 3]
ALABASTER is a Phase 3 trial evaluating tocilizumab in combination with methotrexate for active rheumatoid arthritis in patients with an ina…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating abatacept subcutaneous plus methotrexate for inducing remission in adults with very early rheumatoid arthritis, rep…
-
FDA approval · 2014-10-16FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)
FDA approved a supplemental application for Indocin (indomethacin) submitted by Zyla Life Sciences US LLC.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Home Based Computer Gaming Hand Exercise Regimen for People With Arthritis Affecting the Hands [Phase 2]
Phase 2 trial evaluating a home-based computer game hand exercise program for people with rheumatoid arthritis or hand osteoarthritis has co…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis [Phase 1]
This Phase 1 trial evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of NNC0215-0384 in adults with moderate to seve…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis [Phase 2]
A Phase 2 trial evaluating MP-435 in combination with methotrexate for rheumatoid arthritis has completed, with results posted in 2014.
-
FDA approval · 2014-10-08FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
FDA approved a supplemental application for OTREXUP (methotrexate) submitted by Antares Pharma, Inc.
-
FDA approval · 2014-09-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved Humira's supplemental application submitted by Cordavis Limited. The approval acts as a supplemental approval to the existing H…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies [Phase 3]
This document reports results from an extension study of tocilizumab in rheumatoid arthritis patients who completed core phase 3 trials; res…